Clinical Trials
2 trialsNCT05411718 2026-06-01
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04379999 2025-08-07
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Fox Chase Cancer Center
Phase EARLY_PHASE1 Completed